Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal.
about
Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Azacitidine for Treating Acute ...... e Single Technology Appraisal.
@en
type
label
Azacitidine for Treating Acute ...... e Single Technology Appraisal.
@en
prefLabel
Azacitidine for Treating Acute ...... e Single Technology Appraisal.
@en
P2093
P2860
P50
P1433
P1476
Azacitidine for Treating Acute ...... e Single Technology Appraisal.
@en
P2093
Claudius E Rudin
Joanna L Varley-Campbell
Ruben E Mujica Mota
Tristan M Snowsill
P2860
P2888
P304
P356
10.1007/S40273-016-0453-5
P577
2016-10-17T00:00:00Z